CN Patent

CN101132820A — 预充式针辅助喷射注入器

Assigned to Antares Pharma Inc · Expires 2008-02-27 · 18y expired

What this patent protects

一种喷射注入器，其包括预充式注射器(18)。所述注射器包括包含药物的流体室(22)。所述注射器也具有注射辅助针(24)，柱塞在流体室内可移动。壳体被配置成允许针插入到穿刺深度。能量源被配置成偏压柱塞以在流体室的药物中产生大约80－1000p.s.i.的注射压力，以通过针将药物从流体室喷射注射到注射部位。

USPTO Abstract

一种喷射注入器，其包括预充式注射器(18)。所述注射器包括包含药物的流体室(22)。所述注射器也具有注射辅助针(24)，柱塞在流体室内可移动。壳体被配置成允许针插入到穿刺深度。能量源被配置成偏压柱塞以在流体室的药物中产生大约80－1000p.s.i.的注射压力，以通过针将药物从流体室喷射注射到注射部位。

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: CN101132820A
Jurisdiction: CN
Classification: —
Expires: 2008-02-27
Drug substance claim: No
Drug product claim: No
Assignee: Antares Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.